| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | 18 Sep 2024 | Direct |
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 18 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024107790-sharpless-norman-2024-09-18 | G1 Therapeutics, Inc. | 18 Sep 2024 | 3 | $0 | 4 | Director | 18 Sep 2024, 16:15 |
| /report/000156218024005085-sharpless-norman-2024-06-13 | G1 Therapeutics, Inc. | 13 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:43 |
| /report/000156218023005272-sharpless-norman-2023-06-15 | G1 Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:07 |
| /report/000156218022005921-sharpless-norman-2022-08-04 | G1 Therapeutics, Inc. | 04 Aug 2022 | 1 | $0 | 4 | Director | 05 Aug 2022, 16:15 |
| /report/000156218022005830-sharpless-norman-2022-07-22 | G1 Therapeutics, Inc. | 22 Jul 2022 | 0 | $0 | 3 | Director | 02 Aug 2022, 18:44 |